Shanghai OPM Biosciences CoSHSE:688293 +10.49%81 Piotroski F-Score is 4 as of Jun. 29, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates SHSE:688293 with a GF Score™ of 81/100 and a GF Value™ of ¥37.31 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,339 Biotechnology companies, Shanghai OPM Biosciences Co ranks better than 74.16% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Shanghai OPM Biosciences Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Shanghai OPM Biosciences Co's Piotroski F-Score or its related term are showing as below:
SHSE:688293'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 5 Max: 8
Current: 4
During the past 8 years, the highest Piotroski F-Score of Shanghai OPM Biosciences Co was 8. The lowest was 3. And the median was 5.
Shanghai OPM Biosciences Co (SHSE:688293) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Shanghai OPM Biosciences Co Piotroski F-Score Related Terms
Shanghai OPM Biosciences Co Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai OPM Biosciences Co Piotroski F-Score Chart
SHSE:688293 vs VRTX, REGN, ALNY: Piotroski F-Score Comparison
For the Biotechnology subindustry, Shanghai OPM Biosciences Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai OPM Biosciences Co Piotroski F-Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Shanghai OPM Biosciences Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Shanghai OPM Biosciences Co's current Net Income (TTM) was 66.3.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Shanghai OPM Biosciences Co's current Cash Flow from Operations (TTM) was 55.4.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Shanghai OPM Biosciences Co's return on assets of this year was 0.0287122. Shanghai OPM Biosciences Co's return on assets of last year was 0.00700815.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Shanghai OPM Biosciences Co's gearing of this year was 0.04913233. Shanghai OPM Biosciences Co's gearing of last year was 0.02208428.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Shanghai OPM Biosciences Co's current ratio of this year was 1.89790331. Shanghai OPM Biosciences Co's current ratio of last year was 13.59002052.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Shanghai OPM Biosciences Co's number of shares in issue this year was 560.413. Shanghai OPM Biosciences Co's number of shares in issue last year was 112.831.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Shanghai OPM Biosciences Co's gross margin of this year was 0.46306373. Shanghai OPM Biosciences Co's gross margin of last year was 0.51554377.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Shanghai OPM Biosciences Co's asset turnover of this year was 0.19646834. Shanghai OPM Biosciences Co's asset turnover of last year was 0.13077401.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
0
+
0
+
0
+
0
+
0
+
1
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Shanghai OPM Biosciences Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Shanghai OPM Biosciences Co (SHSE:688293) has a Piotroski F-Score of 4 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai OPM Biosciences Co and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Shanghai OPM Biosciences Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Shanghai OPM Biosciences Co ranks #346 out of 1339 companies in the Biotechnology industry, placing it in the top 25.8%.
Is Shanghai OPM Biosciences Co's Piotroski F-Score too high?
Shanghai OPM Biosciences Co's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Biotechnology industry median Piotroski F-Score is 3.00. Shanghai OPM Biosciences Co's value of 4 is 33.3% above this industry median. Based on the distribution chart, Shanghai OPM Biosciences Co ranks #346 out of 1339 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai OPM Biosciences Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai OPM Biosciences Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai OPM Biosciences Co ranks #346 out of 1339 companies for Piotroski F-Score. This puts Shanghai OPM Biosciences Co in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Shanghai OPM Biosciences Co's value of 4 is 33.3% above this benchmark. Historically, Shanghai OPM Biosciences Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, Shanghai OPM Biosciences Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,339 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai OPM Biosciences Co's current Piotroski F-Score of 4 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai OPM Biosciences Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai OPM Biosciences Co's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai OPM Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co (SHSE:688293) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥37.31, compared to a current price of ¥41.60 — trading 11.5% above its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 33.3% above the Biotechnology industry median of 3.00. Shanghai OPM Biosciences Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai OPM Biosciences Co (SHSE:688293), the current Piotroski F-Score is 4 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai OPM Biosciences Co (SHSE:688293) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co stock appears to be overvalued.
The current stock price of ¥41.60 is trading 11.5% above its estimated GF Value™ of ¥37.31.
GuruFocus considers Shanghai OPM Biosciences Co to be Modestly Overvalued.
Key valuation signals for SHSE:688293:
Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
GF Value™: ¥37.31 vs. price of ¥41.60 (11.5% above fair value)
Industry Position: 33.3% above the Biotechnology median (#346 of 1339)
No single metric tells the full story. See the SHSE:688293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688293 has been successfully added to your 
